Next Article in Journal
How Indonesian Primary Health Care Combat the Spread of COVID-19: Implications for Dealing with Future Pandemics
Previous Article in Journal
The Iridoids of In Vitro Propagated Nepeta cyrenaica Quézel & Zaffran
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs †

Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstr. 48, 48149 Münster, Germany
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/.
Med. Sci. Forum 2022, 14(1), 149; https://doi.org/10.3390/ECMC2022-13487
Published: 2 November 2022
(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)

Abstract

:
G protein-coupled receptors (GPCRs) are omnipresent in the regulation of physiological processes and therefore account for the most prominent drug target class. However, nearly all drugs targeting GPCRs have been developed by the concept of receptors as simple on–off switches. This is surprising, because specifically addressing a distinct intracellular signaling pathway holds the potential to develop safer and more efficient drugs. In recent years, more and more ligands have been reported that shift the naturally imprinted preference of a receptor’s signaling profile, so-called biased ligands. It has been demonstrated for several aminergic GPCRs that an extension of their molecular structure towards extracellular receptor regions results in biased signaling. The underlying mechanism is a specific interference with the allosteric coupling mechanism by which extra- and intracellular sides of the receptor are conformationally linked. We propose a potential blueprint for the design of biased ligands based on the concept of specific interference with the extracellular receptor region and a restriction of its conformational space by extended ligand structures. While this design concept will likely identify new biased ligands, it remains a challenge to specifically design ligands with a desired signaling profile.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13487/s1.

Funding

This research was funded by the German Research Foundation (DFG), grant number: 407626949.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The author declares no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bermudez, M. A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs. Med. Sci. Forum 2022, 14, 149. https://doi.org/10.3390/ECMC2022-13487

AMA Style

Bermudez M. A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs. Medical Sciences Forum. 2022; 14(1):149. https://doi.org/10.3390/ECMC2022-13487

Chicago/Turabian Style

Bermudez, Marcel. 2022. "A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs" Medical Sciences Forum 14, no. 1: 149. https://doi.org/10.3390/ECMC2022-13487

APA Style

Bermudez, M. (2022). A Potential Blueprint for the Design of Biased Ligands for Aminergic GPCRs. Medical Sciences Forum, 14(1), 149. https://doi.org/10.3390/ECMC2022-13487

Article Metrics

Back to TopTop